| Literature DB >> 28033331 |
Ju-Feng Hsiao1, Chang-Min Chung1, Chi-Ming Chu2, Yu-Shen Lin1, Kuo-Li Pan1, Shih-Tai Chang1, Jen-Te Hsu1.
Abstract
OBJECTIVES: Left ventricular remodeling after acute myocardial infarction increases cardiovascular events and mortality. But few study was done in patients with preserved ejection fraction (EF > 40%). We investigate whether the strain and strain rate by 2D speckle tracking echocardiography could predict left ventricular remodeling after acute myocardial infarction in this cohort.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28033331 PMCID: PMC5199037 DOI: 10.1371/journal.pone.0168109
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Illustration of injury longitudinal strain (A) A case with left ventricular remodeling; injury longitudinal strain is –9.2%. (B) A case without left ventricular remodeling: injury longitudinal strain is –12.2%. Abnormal segments are marked with *, which indicates that the longitudinal strain is >–15%.
Patients’ clinical characteristics.
| No remodeling (N = 59) | Remodeling (N = 24) | p Value | |
|---|---|---|---|
| Age (y) | 59.4 ± 12.2 | 64.5 ± 11.4 | 0.08 |
| Male sex | 57 (96.6%) | 18 (75%) | < 0.01 |
| hsCRP (mg/L) | 13.4 (5.8, 41.3) | 30.9 (5.0, 48.4) | 0.56 |
| Peak CK-MB (ng/mL) | 33.6 (5.6, 117.8) | 125.4 (31.7, 300) | 0.01 |
| BNP (ng/L) | 169 (62.3, 312) | 206.5 (139.8, 520.8) | 0.07 |
| eGFR (mL/min/1.73 m2) | 80.8 ± 26.3 | 72.4 ± 26.0 | 0.19 |
| STEMI/NSTEMI | 35 (59.3%)/24 (40.7%) | 19 (79.2%)/5 (20.8%) | 0.09 |
| D-to-B (min) | |||
| • 2022STEMI | 67 (54, 76.5) | 82 (71, 103) | 0.01 |
| • NSTEMI | 1458 (614, 3580) | 853 (78, 2035) | 0.15 |
| S-to-B (h) | |||
| • STEMI | 3.5 (2.3, 6.0) | 3.5 (2.7, 6.8) | 0.68 |
| • NSTEMI | 32 (22, 81) | 17 (9.9, 65) | 0.39 |
| Hypertension | 36 (61%) | 13 (54.2%) | 0.57 |
| Diabetes mellitus | 15 (25.4%) | 7 (29.2%) | 0.73 |
| Smoking | 34 (57.6%) | 14 (58.3%) | 0.95 |
| Medication before discharge | |||
| ACEI or ARB | 25 (42.4%) | 11 (45.8%) | 0.77 |
| Beta-blocker | 31 (52.5%) | 14 (58.3%) | 0.63 |
| Statin | 45 (76.3%) | 13 (54.2%) | 0.05 |
| Culprit vessel | |||
| • LAD | 31 (52.5%) | 9 (37.5%) | 0.43 |
| • LCX | 7 (11.9%) | (12.5%) | |
| • RCA | 21 (35.6%) | 12 (50%) | |
| Coronary artery disease | |||
| • 1-vessel disease | 19 (32.2%) | 7 (29.2%) | 0.81 |
| • 2-vessel disease | 25 (42.4%) | 50%) | |
| • 3-vessel disease | 15 (25.4%) | 5 (20.8%) | |
| Diseased site | |||
| • LM | 7 (11.5%) | 2 (8.3%) | 1.0 |
| • LAD | 53 (89.8%) | 20 (83.3%) | 0.46 |
| • LCX | 25 (42.4%) | 9 (37.5%) | 0.68 |
| • RCA | 36 (61%) | 17 (70.8%) | 0.40 |
| Killip class | 0.42 | ||
| I | 41 (69.5%) | 20 (83.3%) | |
| II | 6 (10.2%) | 1 (4.2%) | |
| III | 4 (6.8%) | 0 | |
| IV | 8 (13.6%) | 3 (12.5%) |
* = p Vale <0.05
‡variables that were not normally distributed were expressed as median (25th, 75th percentile); ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BNP = brain natriuretic peptide; CK-MB = creatine kinase MB isoenzyme; D-to-B = door-to-balloon time; eGFR = estimated glomerular filtration rate; HsCRP = high-sensitivity C-reactive protein; LAD = left anterior descending artery; LCX = left circumflex artery; LM = left main; NSTEMI = non–ST-segment elevation myocardial infarction; RCA = right coronary artery; S-to-B = symptom-onset-to-balloon time; STEMI = ST-segment elevation myocardial infarction.
Echocardiography findings.
| Nonremodeling (N = 59) | Remodeling (N = 24) | p Value | |
|---|---|---|---|
| Baseline echocardiography after admission (days) | 3.3 ± 1.5 | 3.1 ± 2.0 | 0.58 |
| Baseline echocardiography after PCI (days) | 2.6 ± 1.4 | 2.9 ± 2.0 | 0.44 |
| Heart rate (baseline) (bpm) | 72 ± 11 | 75 ± 9 | 0.31 |
| Heart rate (6th month) (bpm) | 71 ± 12 | 68 ± 10 | 0.32 |
| Ejection fraction (baseline) (%) | 58.1 ± 7.3 | 59.3 ± 10.5 | 0.62 |
| Ejection fraction (6th month) (%) | 63.9 ± 7.9 | 56.3 ± 8.0 | <0.01 |
| Left ventricular end-diastolic volume (baseline) (mL) | 111 ± 28 | 86 ± 24 | < 0.01 |
| Left ventricular end-diastolic volume (6th month) (mL) | 107 ± 26 | 117 ± 34 | 0.23 |
| Left ventricular end-systolic volume (baseline) (mL) | 47 ± 15 | 35 ± 13 | < 0.01 |
| Left ventricular end-systolic volume (6th months) (mL) | 39 ± 14 | 52 ± 23 | 0.02 |
| Stroke volume index (mL/m2) | 40 ± 10.7 | 38.6 ± 12.4 | 0.63 |
| Left atrial volume index (mL/m2) | 32.6 ± 10.6 | 34.1 ± 11.1 | 0.61 |
| Mitral inflow | |||
| • E (cm/s) | 82.4 ± 18.6 | 85.3 ± 17.4 | 0.52 |
| • A (cm/sec) | 81.2 ± 23.2 | 89.2 ± 30.1 | 0.2 |
| • E/A | 1.11 ± 0.44 | 1.08 ± 0.47 | 0.78 |
| Deceleration time (ms) | 199 ± 63 | 201 ± 63 | 0.91 |
| Tissue Doppler image | |||
| • E/e′ | 14.6 ± 5.1 | 16.6 ± 5.9 | 0.12 |
| WMSI | 1.26 ± 0.21 | 1.38 ± 0.25 | 0.03 |
* = p Vale <0.05; A = late diastolic wave velocity; a′ = late diastolic wave velocity; E = peak early wave velocity; e′ = peak early diastolic velocity at mitral septum; s′ = systolic velocity at mitral septum by tissue Doppler image; WMSI = wall motion score index.
Left ventricular deformation performance indices.
| Nonremodeling(N = 59) | Remodeling (N = 24) | p Value | |
|---|---|---|---|
| Global longitudinal strain (%) | –18.0 ± 3.6 | –17.0 ± 4.2 | 0.3 |
| Global longitudinal systolic strain rate (s–1) | –1.10 ± 0.21 | –1.07 ± 0.23 | 0.5 |
| Global circumferential strain (%) | –17.6 ± 4.2 | –17.6 ± 5.0 | 0.96 |
| Global circumferential systolic strain rate (s–1) | –1.44 ± 0.39 | –1.46 ± 0.38 | 0.9 |
| Global radial strain (%) | 36.0 ± 12.5 | 37.5 ± 12.3 | 0.66 |
| Global radial systolic strain rate (s–1) | 1.8 ± 0.43 | 1.74 ± 0.32 | 0.61 |
| Culprit longitudinal strain (%) | –16.7 ± 4.2 | –15.5 ± 5.3 | 0.28 |
| Culprit longitudinal systolic strain rate (s–1) | –1.00 ± 0.24 | –0.96 ± 0.3 | 0.51 |
| Injury longitudinal strain (%) | –12.4 ± 1.6 | –10.9 ± 1.7 | <0.01 |
| Injury longitudinal s systolic strain rate (s–1) | –0.81 ± 0.15 | –0.71 ± 0.15 | 0.02 |
| No of injured segments | 5.3 ± 4.8 | 6.8 ± 5.5 | 0.23 |
| Global longitudinal strain (%) | -19.6 ± 3.0 | -18.2 ± 4.0 | 0.1 |
| Global longitudinal systolic strain rate (s–1) | -1.15 ± 0.19 | -0.97 ± 0.22 | <0.01 |
| Global circumferential strain (%) | -19.4 ± 4.5 | -17.9 ± 3.9 | 0.25 |
| Global circumferential systolic strain rate (s–1) | -1.46 ± 0.39 | -1.34 ± 0.26 | 0.26 |
| Global radial strain (%) | 39.3 ± 14.5 | 29.7 ± 15.3 | 0.03 |
| Global radial systolic strain rate (s–1) | 1.76 ± 0.43 | 1.44 ± 0.43 | 0.02 |
| Culprit longitudinal strain (%) | -19.1 ± 3.6 | -17.2 ± 4.7 | 0.07 |
| Culprit longitudinal systolic strain rate (s–1) | -1.11 ± 0.23 | -0.9 ± 0.29 | <0.01 |
| Injury longitudinal strain (%) | -16.6 ± 3.19 | -13.9 ± 3.0 | <0.01 |
| Injury longitudinal systolic strain rate (s–1) | -1.0 ± 0.24 | -0.75 ± 0.25 | <0.01 |
* = p Vale <0.05
Fig 2Receiver operating curve analysis for the prediction of left ventricular remodeling 6 months after acute myocardial infarction (A) for all population (B) for a subgroup of ST-segment elevation myocardial infarction patients.
Univariate and multivariate logistic regression for left ventricular remodeling.
| Univariate analysis odds ratio (95% CI) | p Value | Multivariate analysis odds ratio (95% CI) | p Value | |
|---|---|---|---|---|
| Age (y) | 1.04 (1.0–1.08) | 0.09 | ||
| Male sex | 0.11 (0.02–0.57) | 0.01 | 0.11 (0.02–0.79) | 0.03 |
| Peak CK-MB (ng/mL) | 1.01 (1.00–1.01) | 0.01 | 1.01 (1.0–1.01) | 0.05 |
| log BNP (ng/L) | 2.89 (1.06–7.88) | 0.04 | ||
| log hsCRP (mg/L) | 1.2 (0.54–2.67) | 0.66 | ||
| eGFR (mL/min/1.73 m2) | 0.99 (0.97–1.01) | 0.19 | ||
| LAD disease | 1.77 (0.45–6.92) | 0.41 | ||
| LAD culprit lesion | 1.85 (0.7–4.88) | 0.22 | ||
| D-to-B (min) | ||||
| • STEMI | 1.0 (0.99–1.00) | 0.59 | ||
| • NSTEMI | 1.0 (0.99–1.00) | 0.26 | ||
| S-to-B (h) | ||||
| • STEMI | 0.98 (0.93–1.04) | 0.54 | ||
| • NSTEMI | 0.99 (0.96–1.02) | 0.41 | ||
| ACEI/ARB | 0.87 (0.36–2.26) | 0.77 | ||
| Beta-blocker | 0.79 (0.30–2.05) | 0.63 | ||
| Statin | 2.72 (1.0–7.41) | 0.05 | ||
| Ejection fraction (%) | 1.02 (0.96–1.08) | 0.55 | ||
| WMSI | 9.99 (1.15–87) | 0.04 | ||
| Left atrial volume index (mL/m2) | 1.01 (0.97–1.06) | 0.60 | ||
| Global longitudinal strain (%) | 1.07 (0.94–1.2) | 0.29 | ||
| Global longitudinal systolic strain rate (s–1) | 2.02 (0.23–17.8) | 0.53 | ||
| Global circumferential strain (%) | 1.00 (0.89–1.13) | 0.96 | ||
| Global circumferential systolic strain rate (s–1) | 0.9 (0.23–3.49) | 0.87 | ||
| Global radial strain (%) | 1.01 (0.97–1.05) | 0.65 | ||
| Global radial systolic strain rate (s–1) | 0.7 (0.19–2.66) | 0.6 | ||
| Injury longitudinal strain (%) | 1.7 (1.21–2.39) | < 0.01 | 1.48 (1.02–2.14) | 0.04 |
| Injury longitudinal systolic strain rate (s–1) | 112.3 (1.93–6541.2) | 0.02 | ||
| Culprit longitudinal strain (%) | 1.06 (0.95–1.18) | 0.27 | ||
| Culprit longitudinal systolic strain rate (s–1) | 1.88 (0.29–12.2) | 0.51 |
* = p Vale <0.05; for acronym key, see Table 1.
Clinical data for STEMI patients.
| Nonremodeling (N = 35) | Remodeling (N = 19) | p Value | |
|---|---|---|---|
| Age (y) | 58.3 ± 12.5 | 64.6 ± 11.2 | 0.07 |
| Male sex | 34 (97.1%) | 15 (78.9%) | 0.05 |
| hsCRP(mg/L) | 18.4 (6.2, 56.7) | 38 (7.6, 68.6) | 0.32 |
| Peak CK-MB (ng/mL) | 58.8 (19.1, 216.3) | 165(24.5, 300) | 0.12 |
| BNP (ng/L) | 207 (63, 207) | 343 (145, 844) | 0.03 |
| eGFR (mL/min/1.73 m2) | 84.8 ± 28.1 | 74.6 ± 26.6 | 0.2 |
| D-to-B (min) | 67 (54, 76.5) | 82 (71, 103) | 0.01 |
| S-to-B (h) | 3.5 (2.3, 6.0) | 3.5 (2.7, 6.8) | 0.68 |
| Hypertension | 17 (48.6%) | 9 (47.4%) | 0.93 |
| Diabetes mellitus | 7 (20.0%) | 6 (31.6%) | 0.34 |
| Smoking | 24 (68.6%) | 10 (52.6%) | 0.25 |
| ACEI or ARB | 15 (42.9%) | 9 (47.4%) | 0.75 |
| Beta-blocker | 20 (57.1%) | 12 (63.2%) | 0.67 |
| Statin | 28 (80%) | 11 (57.9%) | 0.08 |
| 0.79 | |||
| • LAD | 18 (51.4%) | (42.1%) | |
| • LCX | 2 (5.7%) | (5.3%) | |
| • RCA | 15 (42.9%) | 10 (52.6%) | |
| 0.8 | |||
| • 1-vessel disease | 11 (31.4%) | (31.6%) | |
| • 2-vessel disease | 18 (51.4%) | 57.9%) | |
| • 3-vessel disease | 6 (17.1%) | 2 (10.5%) | |
| • Left main | 4 (11.4%) | 1 (5.3%) | 0.65 |
| • LAD | 31 (88.6%) | 16 (84.2%) | 0.65 |
| • LCX | 13 (37.1%) | 4 (21.1%) | 0.36 |
| • RCA | 21 (60%) | 14 (73.7%) | 0.38 |
* = p Vale <0.05
‡variables that were not normally distributed were expressed as median (25th, 75th percentile), for acronym key, see Table 1.
Left ventricle deformation performance indices in STEMI patients.
| Nonremodeling (N = 35) | Remodeling (N = 19) | p Value | |
|---|---|---|---|
| Global longitudinal strain (%) | –17.4 ± 3.7 | –16.2 ± 4.3 | 0.27 |
| Global longitudinal systolic strain rate(s–1) | –1.06 ± 0.2 | –1.06 ± 0.26 | 0.99 |
| Global circumferential strain (%) | –16.5 ± 3.9 | –16.7 ± 4.8 | 0.9 |
| Global circumferential systolic strain rate (s–1) | –1.34 ± 0.29 | –1.4 ± 0.35 | 0.53 |
| Global radial strain (%) | 35.6 ± 14.3 | 35.7 ± 12.2 | 0.98 |
| Global radial systolic strain rate (s–1) | 1.76 ± 0.48 | 1.7 ± 0.29 | 0.70 |
| Culprit longitudinal strain (%) | –16.1 ± 4.0 | –14.5 ± 5.4 | 0.21 |
| Culprit longitudinal systolic strain rate (s–1) | –0.96 ± 0.21 | 0.93 ± 0.31 | 0.73 |
| Injury longitudinal strain (%) | –12.3 ± 1.7 | –10.5 ± 1.6 | < 0.01 |
| Injury longitudinal systolic strain rate (s–1) | –0.79 ± 0.13 | –0.72 ± 0.16 | 0.13 |
| No of injured segments | 5.8 ± 5.1 | 8.1 ± 5.5 | 0.14 |
| Global longitudinal strain (%) | -18.9 ± 3.1 | -17.6 ± 4.2 | 0.23 |
| Global longitudinal systolic strain rate (s–1) | -1.1 ± 0.2 | -0.9 ± 0.2 | 0.02 |
| Global circumferential strain (%) | -18.6 ± 4.8 | -17.5 ± 4.0 | 0.51 |
| Global circumferential systolic strain rate (s–1) | -1.3 ± 0.4 | -1.3 ± 0.2 | 0.72 |
| Global radial strain (%) | 38.7 ± 14.2 | 25.5 ± 12.5 | 0.01 |
| Global radial systolic strain rate (s–1) | 1.8 ± 0.5 | 1.3 ± 0.3 | 0.01 |
| Culprit longitudinal strain (%) | -18.4 ± 3.9 | -16.4 ± 4.8 | 0.13 |
| Culprit longitudinal systolic strain rate (s–1) | -1.1 ± 0.2 | -0.9 ± 0.3 | 0.02 |
| Injury longitudinal strain (%) | -16.3 ± 3.4 | -13.6 ± 3.0 | 0.02 |
| Injury longitudinal systolic strain rate (s–1) | -1.0 ± 0.3 | -0.7 ± 0.3 | <0.01 |
* = p Vale <0.05
Univariate logistic regression for left ventricular remodeling in STEMI patients.
| Univariate analysis odds ratio (95% CI) | p Value | |
|---|---|---|
| Age | 1.05 (0.99–1.102) | 0.08 |
| Male sex | 0.11 (0.01–1.07) | 0.06 |
| Peak CK-MB (ng/mL) | 1.01 (1.00–1.01) | 0.06 |
| log BNP (ng/L) | 4.41 (1.19–16.28) | 0.03 |
| log hsCRP (mg/L) | 1.46 (0.53–4.04) | 0.47 |
| eGFR (mL/min/1.73 m2) | 0.99 (0.97–1.01) | 0.2 |
| LAD disease | 1.45 (0.29–7.3) | 0.65 |
| LAD culprit lesion | 0.69 (0.22–2.12) | 0.51 |
| CAD number | 0.86 (0.37–2.00) | 0.72 |
| D-to-B (min) | 1.0 (0.99–1.00) | 0.59 |
| S-to-B (h) | 0.98 (0.93–1.04) | 0.54 |
| ACEI/ARB | 1.20 (0.39–3.69) | 0.75 |
| Beta-blocker | 1.29 (0.41–4.05) | 0.67 |
| Statin | 0.34 (0.1–1.18) | 0.09 |
| Ejection fraction (%) | 1.01 (0.95–1.08) | 0.71 |
| WMSI | 9.16 (0.63–133.0) | 0.11 |
| Left atrial volume index (mL/m2) | 1.02 (0.96–1.09) | 0.59 |
| Global longitudinal strain (%) | 1.09 (0.94–1.26) | 0.26 |
| Global longitudinal strain rate (s-1) | 0.98(0.07–13.04) | 0.99 |
| Global circumferential strain (%) | 0.99 (0.85–1.15) | 0.9 |
| Global circumferential strain rate (s-1) | 0.51(0.07–3.97) | 0.52 |
| Global radial strain (%) | 1.00 (0.96–1.05) | 0.98 |
| Global radial strain rate (s-1) | 0.74 (0.17–3.276) | 0.7 |
| Injury longitudinal strain (%) | 1.88 (1.22–2.88) | < 0.01 |
| Injury longitudinal strain rate (s-1) | 28.72(0.35–2390.8) | 0.14 |
| Culprit longitudinal strain (%) | 1.09 (0.96–1.23) | 0.21 |
| Culprit longitudinal strain rate (s-1) | 1.6(0.16–16.11) | 0.69 |
* = p Vale <0.05; for acronym key, see Table 1.
Echocardiographic findings in STEMI patients.
| Nonremodeling (N = 35) | Remodeling (N = 19) | p Value | |
|---|---|---|---|
| Baseline echocardiography after admission (days) | 2.9 ± 1.4 | 3.3 ± 2.1 | 0.4 |
| Baseline echocardiography after PCI (days) | 2.8 ± 1.4 | 3.3 ± 2.0 | 0.37 |
| Heart rate (baseline) (bpm) | 72 ± 16 | 77 ± 17 | 0.36 |
| Heart rate (6th month) (bpm) | 72 ± 12 | 69 ± 11 | 0.43 |
| Ejection fraction (baseline) (%) | 56.6 ± 7.9 | 57.6 ± 11.3 | 0.7 |
| Ejection fraction (6th month) (%) | 62.8 ± 9.1 | 54.5 ± 7.9 | <0.01 |
| Left ventricular end-diastolic volume (baseline) (mL) | 116 ± 29 | 88 ± 25 | < 0.01 |
| Left ventricular end-diastolic volume (6th month) (mL) | 111 ± 25 | 121 ± 37 | 0.31 |
| Left ventricular end-systolic volume (baseline) (mL) | 51 ± 16 | 37 ± 14 | < 0.01 |
| Left ventricular end-systolic volume (6th months) (mL) | 42 ± 15 | 56 ± 24 | <0.01 |
| Stroke volume index (mL/m2) | 39.6 ± 11.7 | 35 ± 10.7 | 0.18 |
| Left atrial volume index (mL/m2) | 33.3 ± 8.3 | 34.9 ± 11.6 | 0.59 |
| Mitral inflow | |||
| • E (cm/s) | 82.6 ± 18.0 | 86.0 ± 19.1 | 0.52 |
| • A (cm/s) | 79.1 ± 24.1 | 85 ± 31.3 | 0.45 |
| • E/A | 1.15 ± 0.47 | 1.14 ± 0.5 | 0.97 |
| Deceleration time (ms) | 204.6 ± 71.7 | 194.2 ± 66.2 | 0.62 |
| Tissue Doppler image | |||
| • E/e′ | 14.27 ± 5.14 | 16.56 ± 6.05 | 0.16 |
| WMSI | 1.31 ± 0.19 | 1.42 ± 0.26 | 0.1 |
* = p Vale <0.05; for acronym key, see Table 2.